Navigation Links
Multidisciplinary treatment of glioblastoma multiforme can extend patient's life
Date:8/12/2010

Glioblastoma multiforme is the most common form of brain cancer; being an extremely serious type of the disease as currently, on diagnosis, the chances of survival of the patient is less than a year. In fact, its cause is not known nor the manner to prevent it. What is more, progress of patients suffering from this condition has hardly changed in 40 years, unlike other cancers such as, for example, infant leukaemia, for which the possibilities of recovery have risen dramatically.

The Hospital Universitario Donostia (at the city of Donostia-San Sebastin in the Basque province of Gipuzkoa) has incorporated a new glioblastoma multiforme treatment protocol, which could be the starting point for a more effective treatment of this type of cancer. Doctor Nicols Samprn, specialist in Neurosurgery at the hospital, has presented his PhD at the University of the Basque Country (UPV/EHU) based on the first results of the new treatment method. The work is entitled Glioblastoma multiforme. Analysis of survival and prognostic factors.

As Dr Samprn explained, each year there are between three and six cases of glioblastoma multiforme for every 100,000 inhabitants and, thereby, between 30 and 40 new cases correspond to the Hospital Donostia annually. It is not, therefore, an infrequent illness. The new protocol incorporated into the hospital analysed in this thesis puts forward a more multidisciplinary approach to the treatment of patients suffering from this type of cancer. The key figure at the hospital is the Neuro-oncological hospitalisation committee or team, on which neurosurgeons, neurologists, cancer experts, anatomical pathologists, radiologists and others serve; all specialists involved in the care of these patients. The idea is, thus, to provide a more personalised treatment and monitoring.

17 months

According to the thesis, this new multidisciplinary approach gives better survival rates; the usual average survival rate for a patient with glioblastoma multiforme having been 12 months, after the incorporation of this treatment it has risen to 17 months and a half.

The thesis also highlights a finding as regards determining factors for prognosis. As Dr. Samprn pointed out, the general health situation of the patient at the moment of the diagnosis is the most efficacious indicative factor when predicting the most favourable prognosis, whereas molecular studies have not provided conclusive results with respect to this prognosis.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. CIHR team grant to fund multidisciplinary breast cancer survivorship studies
2. Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder
3. NIH award will enable design of brain tumor treatment that captures migrating cancer cells
4. New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
5. New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
6. Surgery better than radiation, hormone treatments for some prostate cancer, study shows
7. Drug control efforts in Mexico reduce methamphetamine treatment admissions in Mexico and US
8. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
9. Iron oxide nanoparticles becoming tools for brain tumor imaging and treatment
10. Ketamine Eased Depression in Treatment-Resistant Bipolar Disorder
11. New studies question vascular multiple sclerosis hypothesis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: